Organisation paid for research Program year 2025 Source: CMS Open Payments

Advanced Cardiovascular - Alexander City

Neither a doctor nor a teaching hospital

Research payments

$255,933

8 payments

Through program year 2025, Advanced Cardiovascular - Alexander City is reported as receiving $255,933 in research payments, across 8 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$56,800	2
2024	Research	$50,886	3
2023	Research	$148,248	3

Breakdown

Who paid Research payments · program years 2023–2025

Merck Sharp & Dohme Corporation $255,933 8 payments

Studies the money was for Research payments · program years 2023–2025

A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of the sGC Stimulator Vericiguat,MK-1242 in Adults With Chronic Heart Failure With Reduced Ejection Fraction $199,134 6 payments
A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of the sGC Stimulator Vericiguat,MK-1242 in Adults With Chronic Heart Failure With Reduced Ejection Fraction $51,335 1 payment
A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of the sGC Stimulator Vericiguat,MK-1242 in Adults With Chronic Heart Failure With Reduced Ejection Fraction $5,465 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.